Glenmark initiates multi-nation Phase 3 clinical trial for lung cancer drug
(*3*) Glenmark Pharmaceuticals on Friday (September 5, 2025) mentioned it has initiated a multi-country Phase 3 clinical trial for Envafolimab, a novel drug for third-stage non-small cell lung cancer. Glenmark
